Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added the related topic 'Squamous cell carcinoma of the head and neck' and an external resource 'Genetic and Rare Diseases Information Center' under Resources.
    Difference
    0.2%
    Check dated 2026-04-02T15:22:42.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:17:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3; no changes to study content or page functionality are indicated.
    Difference
    0.1%
    Check dated 2026-03-11T23:57:06.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-02-11T11:30:08.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations status, with guidance to check opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Show glossary feature added and QC metadata labels updated, including a revision/version tag. Core trial data and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:58.000Z thumbnail image

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.